论文部分内容阅读
目的:探讨和分析脂肪肝与体重指数、血脂、肝功能的相关性,为防治脂肪肝提供依据。方法:选取2010年1月至2014年2月来我院进行健康体检的600例人员为研究对象,根据肝脏超声检查结果分为两组,脂肪肝组和非脂肪肝组。对两组人员的体重指数(BMI)、血脂、肝功能指标等数据进行相关性分析研究。结论:肝脏超声检查出脂肪肝患者260例,非脂肪肝人员340例,脂肪肝组中BMI增高的有175例,所占比例为67.3%;血脂异常(包括总胆固醇、三酰甘油、低密度脂蛋白和高密度脂蛋白)的有66例,所占比例为25.4%;肝功能异常(包括谷丙转氨酶、谷草转氨酶、谷氨酰转肽酶)的有80例,所占比例为30.8%。而非脂肪肝组中BMI增高的有70例,所占比例为20.6%;血脂异常的有25例,所占比例为7.4%;肝功能异常的有15例,所占比例为4.4%。两组比较差异具有统计学意义(P<0.05)。
Objective: To investigate and analyze the correlation between fatty liver and body mass index, blood lipid and liver function, and to provide basis for prevention and treatment of fatty liver. Methods: From January 2010 to February 2014 to our hospital for physical examination of 600 staff for the study, according to the results of liver ultrasound divided into two groups, fatty liver group and non-fatty liver group. Two groups of people’s body mass index (BMI), blood lipids, liver function index data correlation analysis. CONCLUSIONS: There are 260 cases of fatty liver diagnosed by liver ultrasonography and 340 cases of non-fatty liver. The patients with fatty liver have 175 cases of increased BMI, accounting for 67.3%. The levels of total dyslipidemia (including total cholesterol, triglyceride, low density Lipoprotein and high-density lipoprotein) in 66 cases, accounting for 25.4%; liver dysfunction (including alanine aminotransferase, aspartate aminotransferase, glutamyl transpeptidase) in 80 cases, the proportion of 30.8% . The non-steatohepatitis group had 70 cases of increased BMI, accounting for 20.6%; 25 cases of dyslipidemia, accounting for 7.4%; 15 cases of liver dysfunction, the proportion of 4.4%. The difference between the two groups was statistically significant (P <0.05).